On Sale
Pet CBD Oil - For Small Dogs and Cats Zilis UltraCell - Water Soluble, Full-Spectrum Salmon
Pet CBD Oil - Zilis UltraCell - Water Soluble, Full-Spectrum Salmon
For Small Dogs & Cats
For Small Dogs & Cats
UltraCell Pet's savory salmon flavor is the perfect potency for cats & smaller dogs. For pet dosing see our Info Page. For more information see our UltraCell Pet Flyer PDF.
Zilis UltraCell Pet is a potent, full-spectrum water-soluble CBD Oil with 94% absorption and 12-hour full-spectrum bio-availability. Crafted from organic Colorado-sourced CBD oil, UltraCell is rich in phytocannabinoids. UltraCell Pet is the highest quality CBD oil you can buy – It’s highly concentrated water-based formula aids absorption; it's quickly bio-available & in lower doses, saving money.
- 100% water-soluble
- No Saccharine, No Xylitol, & No Stevia
- Organic Colorado-sourced CBD oil
- It’s Full-Spectrum
- 94% absorbable saving money in lower doses.
- bottled in glass, not plastic, with a glass liquid dropper.
Ingredients: Full-spectrum hemp CBD Oil, Purified water , Salmon Oil,, Glycerin (from coconut) , Natural flavors (plant extracts) , Natural lipids (from non-GMO sunflower seeds) , Prebiotic polysaccharides (from Xanthan and Acacia Gum) , Potassium Sorbate
Directions:
Shake before using. Take 1 mL orally daily or as directed by veterinarian. please see Info Page for suggested dosage. Do not exceed more than 4 drops per 5 pounds of body weight, twice per day. Consult your vet before using. Not intended for use by pregnant or nursing women or anyone under age 18. Keep out of reach of children.
The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA- approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act require this notice.
The Department of Health and Human Services of the US Federal Government owns the patent #6,630,507.